Ed Bass Group

The Ed Bass Group is a private investment firm and family office based in Fort Worth, Texas, led by billionaire Edward P. Bass. The group manages a diversified portfolio with significant interests in oil and gas, real estate, and venture capital, including strategic investments in the life sciences and healthcare sectors. Notably, the group led a major funding round for MonoSol Rx (now Aquestive Therapeutics), supporting the development of proprietary thin-film drug delivery technologies. Beyond direct investments, Ed Bass is a prominent philanthropist known for funding large-scale scientific endeavors such as the Biosphere 2 project and the Human Immunome Project. The group often operates through its management arm, Fine Line, to oversee its venture capital and private equity activities. Its involvement in the life sciences is characterized by a focus on innovative technologies and scientific research that addresses global health challenges.